Daily Archives: October 22, 2014

aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research

– Architect of Novel Translational Rare Disease Programs at NIH Adds Depth to Existing Team of Rare Disease Experts SAN DIEGO and HONG KONG, Oct. 22, 2014 /PRNewswire/ — aTyr Pharma…

Public Health Sector Offers Immense Opportunities for Global Wound Care Market

– Strong relationships with end users and an effective post sales service strategy must be a priority for wound care companies, says Frost & Sullivan LONDON, Oct. 22, 2014 /PRNewswire/…

Foundation Medicine and WuXi PharmaTech Announce Strategic Collaboration to Offer Best-in-Class Comprehensive Genomic Profiling in China

Collaboration to address needs of biopharmaceutical companies conducting clinical R&D in China CAMBRIDGE, Mass. and SHANGHAI, October 22, 2014 /PRNewswire/— Foundation Medicine, Inc. (NASDAQ:FMI) and WuXi PharmaTech (Cayman) Inc. (NYSE:WX)…

Golden Meditech Brings in Strategic Investor through the Issuance of Convertible Notes

HONG KONG, Oct. 22, 2014 /PRNewswire/ — Golden Meditech Holdings Limited (the "Company" or "Golden Meditech", 801.HK; 910801.TW), a leading integrated healthcare enterprise in China, announced that it has brought…

Frost & Sullivan Recognises Europe’s Top Achievers at Excellence in Best Practices Awards Banquet in Monaco

– More than 20 awards to be presented for exemplary best practices LONDON, Oct. 22, 2014 /PRNewswire/ — Frost & Sullivan will host its Excellence in Best Practices Awards Banquet at…

Tianyin Pharmaceutical Received Notices of Non-Compliance from NYSE MKT

CHENGDU, China, October 22, 2014 /PRNewswire/ — Tianyin Pharmaceutical Inc. (NYSE MKT: TPI, the “Company”), a pharmaceutical company that specializes in the development and sale of patented biopharmaceutical medicine, modernized…